GlobalData on MSN11h
Phoenix Molecular kicks off Phase II part of breast cancer combo trial
The Phase II portion is seeking to establish safety and efficacy of the company’s HER2 breast cancer therapy in combination ...
precisionmedicineonline8h
Phoenix Molecular Designs Launches Phase II Trial in RSK2-High Breast Cancer
In a previous trial, patients with RSK2-high cancers had a significantly greater benefit from treatment with PMD-026 than those with RSK2-low cancers.